Genesis Labs Limited
About Genesis Labs Limited
Data last updated:
Genesis Labs Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 September 2005.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PLC155922. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15.72 Lakh. It is led by directors including Karan Harshad Mengar and Sangeeta Srivastava Arunkumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Somaiya Bhavan 45/47 Mahatma Gandhi Road Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹42,006, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹63,853 (net margin -152%) and EBITDA of -₹63,853 (EBITDA margin -152%).
As per MCA filings, the company has satisfied charges of ₹1.88 Cr on record.
Company details
Contact details
Genesis Labs Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSomaiya Bhavan 45/47 Mahatma Gandhi Road Fort, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Genesis Labs Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Genesis Labs Limited
FY 2025 filings availableGenesis Labs Limited reported revenue of ₹42,006 (up 1100% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹63,853 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹63,853 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -152% | ||||
| Net Profit Margin | -152% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genesis Labs Limited, buy the company report.
Board of directors of Genesis Labs Limited
Genesis Labs has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karan Harshad Mengar | Director | 17 Mar 2023 | 3 Years 7 Months | Current |
| Sangeeta Srivastava Arunkumar | Director | 06 Sep 2005 | 21 Years 2 Months | Current |
| Naresh Khetan Sitaram Also directs: Sakarwadi Trading Company Private Limited, Karnataka Organic Chemicals Private Limited, The Book Centre Private Limited and 3 more | Director | 06 Sep 2005 | 21 Years 2 Months | Current |
Auditor
Genesis Labs Limited is audited by Y.S. Muzumdar & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y.S. Muzumdar & Co. | FY 2017 | 33704 |
Shareholding
The shareholding of Genesis Labs Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Genesis Labs Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Sep 2006 | 10062615 | Bank of Maharashtra | ₹94 Lakh | Satisfied | |
| 26 Sep 2006 | 10062614 | Bank of Maharashtra | ₹94 Lakh | Satisfied |
To see the full charge records of Genesis Labs Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Genesis Labs Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genesis Labs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genesis Labs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Genesis Labs Limited, buy the company report.
Recent activity
Genesis Labs Limited has 8 board changes on record since 2005: 3 appointments and 5 cessations. The latest: Karan Harshad Mengar ceased to be Additional Director on 31 Jul 2023.
3 earlier events are in the company report.
Frequently asked questions
Genesis Labs is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Genesis Labs is a company pending strike off, currently registered as a public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 September 2005 and is registered under CIN U24230MH2005PLC155922. The company may be struck off soon - caution is advised.
The compliance status of Genesis Labs is compliant as of 07 August 2026.
Genesis Labs has 3 current directors:
- Karan Harshad Mengar - Director
- Sangeeta Srivastava Arunkumar - Director
- Naresh Khetan Sitaram - Director
The CIN (Corporate Identification Number) of Genesis Labs is U24230MH2005PLC155922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genesis Labs was incorporated on 06 September 2005. It is registered with the Registrar of Companies, Mumbai.
The registered office of Genesis Labs is at Somaiya Bhavan 4547 Mahatma Gandhi Road Fort, Mumbai, Maharashtra, India – 400001.
The latest financial statements of Genesis Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Genesis Labs has 1 GST registration on record and it is cancelled or inactive.
Genesis Labs operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
